Yongmei Xu

Shanghai Medicilon Inc.

Shanghai Medicilon Inc was founded in 2004 with the explicit purpose of providing fully integrated pharmaceutical research and development to the global pharmaceutical community. To provide the best service Shanghai Medicilon Inc. is organized in three departments: biology, chemistry and preclinical through Medicilon/MPI. In this way the company has the ability to provide specific services in each sector, and at the same time, competences from the other departments to provide fully integrated services. Shanghai Medicilon Inc has been recognized as one of the top drug discovery contract research organizations in China and is managed by a team of scientists with many years of experience in US-based pharmaceutical and biotechnology companies. Shanghai Medicilon Inc has a strictly professional research team, with over 1000 scientists. We have expertise, experience and resources to devise, implement, and support all your research needs. We take pride in maintaining an open dialogue with our customers and upholding our commitments to intellectual property protection and client confidentiality. In this way we're always able to deliver a neutral and professional research for our clients. As our areas of expertise and service capabilities continue to expand, major pharmaceutical and biotechnology companies from across 4 continents have taken advantage of our integrated drug discovery and development services.